ArticleBMJ open2025
Is sports-branded screening effective in identifying adults at greatest risk of developing cardiovascular disease: a convergent parallel mixed-methods design to identify adults at greatest risk of developing cardiovascular disease using an opportunistic sports-branded health screening approach in the community.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo establish whether sports-branded screening is effective in identifying adults at risk of developing cardiovascular disease (CVD); to determine whether the public would engage with sports-branded health screening and what their experiences were.
designConvergent parallel mixed methods.
settingMass screening at Liverpool Football Club Foundation events at four community centres.
participants100 participants (mean age 46.6 years (SD 14.7), range 20-84 years) were recruited, and their risk factors were identified. Of these, 62 were screened for their SCORE 2 CVD risk. Men and women were equally represented. Participants were predominantly white British (93%).
interventionsA dedicated screening area was established at each venue. Data to calculate SCORE 2/OP risk scores were captured (gender, smoking status, age, blood pressure and lipids). Additional risk factors (glucose, incident atrial fibrillation and body mass index (BMI)) were measured to assess wider heart health. A purposive sample of 12 participants participated in a semistructured, one-to-one audio recorded interview about their experience. PRIMARY AND SECONDARY OUTCOME MEASURES: Outcomes were the SCORE 2 and SCORE 2/OP risk tool; ability to recruit participants and whether sports-branded screening was acceptable to participants.
resultsParticipants ranged from 20 to 84 years with a mean age of 46.6 years. Men and women were equally represented. Participants were predominantly white British, with 41% and 40% recording a higher than normal total cholesterol and low-density lipoprotein cholesterol (LDL-C) level, respectively, and 36% recording lower than normal LDL-C level. 20% of participants recorded a blood pressure greater than 140/90 mm Hg and 21% of participants were smokers. Mean BMI was 29, ranging from 17.8 to 51, with 70% of the participants classified as overweight or obese. CVD risk ranged from <1% to 15%. 21 participants had a 10-year risk of fatal and non-fatal CVD events greater than the estimated risk for their age. Participants reported that they would not have organised a GP health check or had struggled to book a GP appointment and found mass testing to be convenient, quick and easy.
conclusionsSports-affiliated branding was well received and identified a significant number of people with high 10-year risk of CVD plus additional risk factors. All participants interviewed spoke positively about the experience. Immediately providing results, alongside individualised health promotion, allowed participants to understand their risk of CVD and the need for a change of lifestyle.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.